MX2024006556A - Inhibidores de peptido del receptor de interleucina-23. - Google Patents
Inhibidores de peptido del receptor de interleucina-23.Info
- Publication number
- MX2024006556A MX2024006556A MX2024006556A MX2024006556A MX2024006556A MX 2024006556 A MX2024006556 A MX 2024006556A MX 2024006556 A MX2024006556 A MX 2024006556A MX 2024006556 A MX2024006556 A MX 2024006556A MX 2024006556 A MX2024006556 A MX 2024006556A
- Authority
- MX
- Mexico
- Prior art keywords
- interleukin
- peptide inhibitors
- receptor peptide
- compounds
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21211815 | 2021-12-01 | ||
| PCT/EP2022/084077 WO2023099669A1 (en) | 2021-12-01 | 2022-12-01 | Peptide inhibitors of interleukin-23 receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024006556A true MX2024006556A (es) | 2024-06-12 |
Family
ID=78821013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024006556A MX2024006556A (es) | 2021-12-01 | 2022-12-01 | Inhibidores de peptido del receptor de interleucina-23. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250154198A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4440592A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024543204A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240111800A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118354781A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022402440A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3240982A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024001598A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL313185A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024006556A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202332682A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023099669A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4471048A1 (en) * | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) * | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| CN121794283A (zh) * | 2023-09-08 | 2026-04-03 | 赛诺菲 | 作为选择性il-23受体抑制剂的新型肽 |
| WO2026013260A1 (en) | 2024-07-12 | 2026-01-15 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2026026815A1 (zh) * | 2024-07-30 | 2026-02-05 | 西藏海思科制药有限公司 | 白介素-23受体的肽抑制剂及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ295838B6 (cs) | 1996-09-09 | 2005-11-16 | Zealand Pharma A/S | Způsob výroby peptidů |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| HK1257747A1 (zh) | 2015-07-15 | 2019-10-25 | Protagonist Therapeutics Inc. | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| WO2018022937A1 (en) | 2016-07-27 | 2018-02-01 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 and their use to treat inflammatory diseases |
| US20200064357A1 (en) * | 2016-11-09 | 2020-02-27 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
| JP2020505352A (ja) | 2017-01-18 | 2020-02-20 | プロタゴニスト セラピューティクス, インコーポレイテッド | インターロイキン−23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| CA3104418A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2020311395A1 (en) | 2019-07-10 | 2022-02-03 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| MX2022008740A (es) * | 2020-01-15 | 2022-09-23 | Janssen Biotech Inc | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. |
| WO2021146458A1 (en) | 2020-01-15 | 2021-07-22 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| SMT202500254T1 (it) | 2020-01-15 | 2025-09-12 | Janssen Biotech Inc | Inibitori peptidici del recettore dell'interleuchina-23 e loro uso per trattare malattie infiammatorie |
-
2022
- 2022-12-01 AU AU2022402440A patent/AU2022402440A1/en active Pending
- 2022-12-01 TW TW111146213A patent/TW202332682A/zh unknown
- 2022-12-01 CN CN202280079717.2A patent/CN118354781A/zh active Pending
- 2022-12-01 WO PCT/EP2022/084077 patent/WO2023099669A1/en not_active Ceased
- 2022-12-01 KR KR1020247021622A patent/KR20240111800A/ko active Pending
- 2022-12-01 JP JP2024532708A patent/JP2024543204A/ja active Pending
- 2022-12-01 EP EP22830694.0A patent/EP4440592A1/en active Pending
- 2022-12-01 IL IL313185A patent/IL313185A/en unknown
- 2022-12-01 MX MX2024006556A patent/MX2024006556A/es unknown
- 2022-12-01 CA CA3240982A patent/CA3240982A1/en active Pending
- 2022-12-01 US US18/715,410 patent/US20250154198A1/en active Pending
-
2024
- 2024-05-28 CL CL2024001598A patent/CL2024001598A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022402440A1 (en) | 2024-05-30 |
| CA3240982A1 (en) | 2023-06-08 |
| IL313185A (en) | 2024-07-01 |
| JP2024543204A (ja) | 2024-11-19 |
| EP4440592A1 (en) | 2024-10-09 |
| CN118354781A (zh) | 2024-07-16 |
| KR20240111800A (ko) | 2024-07-17 |
| CL2024001598A1 (es) | 2024-11-15 |
| TW202332682A (zh) | 2023-08-16 |
| WO2023099669A1 (en) | 2023-06-08 |
| US20250154198A1 (en) | 2025-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2024001598A1 (es) | Inhibidores de péptido del receptor de interleucina-23 | |
| MX2022008741A (es) | Inhibidores de peptidos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. | |
| MX2022000397A (es) | Inhibidores peptídicos del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. | |
| MA58170B1 (fr) | Dérivés carboxy avec des proprietes anti-inflammatoires | |
| MX2022008740A (es) | Peptidos inhibidores del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias. | |
| EA201890618A1 (ru) | Способы и композиции для лечения состояний, ассоциированных с аномальными воспалительными ответами | |
| JOP20230186A1 (ar) | أجسام مضادة لـ cd30l واستخداماتها | |
| EP3999121A4 (en) | TREATMENT/PREVENTION OF DISEASE BY INHIBITION OF LING COMPLEX | |
| EP3601531C0 (en) | TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH LIVE BIOTHERAPEUTICS | |
| MA31668B1 (fr) | Polypeptides, domaines variables d'anticorps et antagonistes | |
| MA31767B1 (fr) | Composes organiques et leurs utilisations | |
| EA200971130A1 (ru) | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний | |
| MA50013B1 (fr) | Analogues de benzoazépine utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton | |
| NO20071343L (no) | Substituerte fenylaminotiazoler og anvendelse derav | |
| WO2005072113A3 (en) | Compositions and methods of treatment for inflammatory diseases | |
| EP3737376A4 (en) | SELECTIVE HISTONE ACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASES | |
| MX2022011697A (es) | Inhibidores de ciclofilina y usos de los mismos. | |
| EA202190952A1 (ru) | Соединения и композиции для лечения патологических состояний, связанных с активностью рецептора apj | |
| EA202190310A1 (ru) | Белок для лечения воспалительных заболеваний | |
| MX2022008265A (es) | Compuestos y metodos para el tratamiento del dolor visceral. | |
| PH12020500204A1 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic disease | |
| EP3440045A4 (en) | PREVENTING, TREATING AND REVERSING DISEASES USING THERAPEUTICALLY ACTIVE AMOUNTS OF DICARBONIC ACID COMPOUNDS | |
| EA202190452A1 (ru) | Ингибиторы cdk8/19 | |
| WO2022093552A3 (en) | Rev-erb agonists | |
| EP3806865A4 (en) | MODIFIED TETRACYCLINE FOR THE TREATMENT OF ALCOHOL ABUSE, PAIN AND OTHER DISEASES WITH POTENTIAL INFLAMMATORY PROCESSES |